Latest Info.
Help us Stop PBM Abuse
Welcome to our dedicated Hub, your go-to source for the most up-to-date news and essential information about Pharmacy Benefit Managers (PBMs). Our aim is to provide you with a simplified and comprehensive platform where you'll find everything you need to know about PBMs.
Watch this video from WSJ
How Drug Prices Work: Drug pricing is complicated and secretive. WSJ explains how the flow of money, drugs and rebates behind the scenes may drive up the price of prescription medicine for consumers.
Arm Yourself with Knowledge.
Resources to Combat PBM and Insurer Abuses
We have taken a proactive approach in advocating for pharmacists and their patients by assembling a comprehensive library of resources, templates, and knowledge for healthcare providers who face barriers and abuses from PBMs and insurers. By leveraging this collection of resources, practitioners can arm themselves with the necessary expertise and information to take decisive action against the unfair practices that harm their patients and hinder the development of their practices.
Resources:
Trump Affirms Commitment to PBM Reform
Pharmacy Groups “Key Vote” CR with Real PBM Reforms
How Drug Prices Work (WSJ)
Bipartisan lawmakers want to force health insurers, PBMs to sell off pharmacies
Senator Hawley Speaks on Bill To Lower Cost Of Prescription Drugs at Press Conference (YouTube)
Cut out the middleman and get prescription drug prices down (Washington Times)
It’s Time To End the PBM Shakedown (Forbes)
Biden administration’s fee limits on PBMs backfires, say pharmacists (Benefits PRO)
Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs (WSJ)
Spending on health care in US rises to $4.5 trillion in 2022; a return to pre-pandemic growth rates (Missouri Independent)
Generic Drugs Should Be Cheap, But Insurers Are Charging Patients Thousands of Dollars For Them (WSJ)
The Association Between Drug Rebates and List Prices (USC Schaeffer)
Billionaire Investor Mark Cuban: There's nothing unique about the big three PBMs (CNBC)
Cash crunch pushes independents to the brink, data shows (NCPA)
Bernskoetter, Fitzwater sponsor bills regulating pharmacy choices (News Tribune)